SYRE Competitors & Alternatives
Compare Spyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
SYRE
Main Stock$90.60
Tradestie Score
66
Market Cap
$994.20M
Analyst Upside
+32.5%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TECH
Bio-Techne Corp.
|
$72.12
|
$9.33B | 62.1 | 51 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$112.79
|
$8.88B | 255.4 | 58 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$107.20
|
$8.77B | 31.5 | 48 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$203.77
|
$8.57B | - | 45 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$24.34
|
$8.53B | 2.5 | 40 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$245.80
|
$8.30B | 16.5 | 59 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$73.77
|
$6.68B | - | 53 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$104.71
|
$6.64B | - | 62 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$118.64
|
$6.38B | - | 56 | Compare |
More SYRE Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry